Alto Neuroscience, Inc. · NYSE:ANRO
BlackRock, Inc.'s stake in Alto Neuroscience, Inc. fell to 2.10% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in Alto Neuroscience, Inc. fell to 2.10%, 561,363 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 2.10%
- Shares
- 561,363
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 2.10% | 561,363 |
Source
Related
- Alto Neuroscience, Inc.
- BlackRock, Inc.
- Alto Neuroscience, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026